AT-Patch (ATP-C130/ATP-C70) vs CardIQ Suite
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require continuous, long-term ambulatory ECG monitoring for up to 14 days to detect intermittent arrhythmias or evaluate cardiac symptoms in a patient's daily life. Its lightweight, shower-proof design and integrated AI analysis are ideal for patient comfort and efficient arrhythmia detection without requiring active patient management during the monitoring period.
View AT-Patch (ATP-C130/ATP-C70) →Choose CardIQ Suite if…
Choose CardIQ Suite if you need advanced, AI-powered post-processing and analysis of cardiac CT scans for comprehensive cardiovascular disease diagnosis and treatment planning. This tool is best suited for detailed assessment of coronary artery calcium scoring, plaque burden, and CCTA review, providing critical anatomical and structural insights for radiologists and cardiologists.
View CardIQ Suite →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | CardIQ Suite |
|---|---|---|
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | On-premise (integrated with CT systems) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch offers superior usability from a patient perspective, being a comfortable, shower-proof wearable that requires minimal patient interaction during extended monitoring. While CardIQ Suite streamlines complex clinician workflows, AT-Patch's ease of use for data collection by patients, combined with its automated analysis, makes it more broadly 'usable' across the care continuum.
Clinical Value
CardIQ SuiteCardIQ Suite offers a broader and deeper diagnostic capability for structural heart disease and coronary artery disease, including quantitative plaque burden and calcium scoring, which are critical for risk stratification and treatment planning. While AT-Patch is excellent for arrhythmia detection, CardIQ Suite's comprehensive imaging analysis provides more extensive insights into overall cardiovascular health.
Pricing & Value
TieBoth tools lack transparent public pricing, making a direct comparison of their value difficult. AT-Patch's pricing is not publicly available and involves direct sales, while CardIQ Suite requires contacting the vendor for pricing. Without specific cost information for either product, it is impossible to determine which offers better value.
Enterprise Readiness
CardIQ SuiteCardIQ Suite demonstrates stronger enterprise readiness with explicit confirmation of HIPAA compliance and the availability of a Business Associate Agreement (BAA). As a GE product, it also benefits from integration with established imaging infrastructure and a large vendor's support ecosystem, which are crucial for large healthcare organizations.
Innovation
CardIQ SuiteCardIQ Suite's application of deep learning for automated and comprehensive analysis of complex cardiac CT data, including calcium scoring and plaque characterization, represents a more advanced and impactful innovation in diagnostic imaging. While AT-Patch innovates in wearable monitoring, CardIQ Suite's AI directly enhances the interpretation of intricate anatomical and pathological information.
Support & Docs
CardIQ SuiteGE HealthCare (Tool B) has a more robust and clearly articulated support and documentation framework, including dedicated technical support, remote assistance options, and comprehensive manuals for its imaging software products. ATsens (Tool A) offers basic documentation and contact options, but not the same breadth of enterprise-level support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | CardIQ Suite |
|---|---|---|
| Tool Name | AT-Patch (ATP-C130/ATP-C70) | CardIQ Suite |
| Company | ATsens Co. | GE Medical Systems SCS |
| Description | FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy, a shower-proof design, and integrated AI-powered analysis software for enhanced arrhythmia detection. | AI-powered cardiac CT post-processing application offering automated calcium scoring and CCTA review for comprehensive cardiovascular disease diagnosis and treatment planning. |
| Primary Category | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Key Feature (Monitoring/Analysis) | Up to 14 days of continuous ECG monitoring (ATP-C130) with AI/machine learning algorithms for ECG analysis. | Deep Learning based automated Calcium Score and labeling of coronary artery territories. |
| Key Feature (Design/Review) | Shower-proof design (IP57 for ATP-C130, IP44 for ATP-C70) and compact/lightweight (13g). | Integrated workflow for seamless review of calcium scoring and CCTA data, with CCTA 2D Review and cine capability. |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and CardIQ Suite.